Acinetobacter baumannii: An emerging and important pathogen

Journal of Clinical Outcomes Management

Volumn 17, Issue 8, 2010, Pages 27-35

  Alsan, Marcella ^a   Klompas, Michael ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; COLISTIN; ERTAPENEM; IMIPENEM; MEROPENEM; SULBACTAM; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERICIDAL ACTIVITY; CONTAMINATION; CRITICALLY ILL PATIENT; EPIDEMIC; HOSPITAL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; MEDICAL INSTRUMENTATION; NONHUMAN; PATHOGENESIS; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 78649738113     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Micro Rev 2008;21:538-82.
2. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JA, et al. Manual of clinical microbiology. 8th ed. Washington DC: American Society Microbiology; 2003:749-79.
3. Fournier PY, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infec Dis 2006;42:692-9.
4. Seifert HL, Dijkshoorn P, Gerner-Smidt N, et al. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1991;35:2819-25.
5. La Scola B, Raoult D. Acinetobacter baumannii in the human body louse. Emerg Infect Dis 2006;10:1671-3.
6. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly 2004;53:1063-6.
7. Griffith M, Ceremuga J, et al. Acinetobacter skin colonization of U.S. army soliders. Infect Control Hosp Epidemiol 2006;27:659-61.
8. Griffith ME, Lazarus DR, Mann PB, et al. Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect Control Hosp Epidemiol 2007;28:720-2.
9. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the U.S. military health care system associated with military operations in Iraq. Clin Infect Dis 2007;44:1577-84.
10. Moran KA, Murray CK, Anderson EL. Bacteriology of blood, wound, and sputum cultures from non-U.S. casualties treated in combat support hospital in Iraq. Infect Control Epidemiol 2008;29:981-4.
11. McDonald LC, Banerjee S, Jarvia WR, and the National Nosocomial Infections Surveillance System. Seasonal variation of Acinetobacter infections 1987-1988. Clin Infect Dis 1999;29:1133-7.
12. McDonald LC, Walker M, Carson L, et al. Outbreak of Acinetobacter spp. bloodstream infections in a nursery associated with contaminated aerosols and air conditioners. Pediatr Infect Dis J 1998;17:716-22.
13. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24:284-95.
14. Neely AN, Maley P, Warden GD. Computer keyboards as a reservoir for Acinetobacter baumannii in a burn hospital. Clin Infec Dis 1999;29:1358-9.
15. Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006;44:3623-7.
16. Turton JF, Kaufmann ME, Warner M, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 2004;58:170-9.
17. Da Silva, Dijkshoorn GL, van der Reijden T, et al. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 2007;13:190-5.
18. Naas TB, Coignard A, Carbonne K, et al. VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006;12:1214-22.
19. Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994;344:1329-32.
20. Lolans K, Rice TW, Munoz-Price LS, Quinn JP, Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agent Chemother 2006;50:2941-5.
21. Allen DM, Jarman BJ. Acinetobacter species. In: Mandell, Douglas, Bennett. Principles and practices of infectious diseases. 7th ed. New York: Elsevier; 2010:2881-6.
22. Wadl M, Heckenback K, Noll I, et al. Increasing occurrence of multi-drug resistant in Acinetobacter baumannii isolates from four German university hospitals 2002-2006. Infection 2010;38:47-51.
23. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006;43:Suppl 2:S49-56.
24. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008;358:1271-81.
25. Doi Y, Adams JM, Yamane K, et al. Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America. Antimicrob Agents Chemother 2007;51:4209-10.
26. Fournier PE, Vallenet V, Berbe S, et al. Comparative genomes of multidrug resistance in Acinetobacter baumanii. PLoS Genet 2006;2:e7.
27. Jawad A, Snalling AM, Heritage J, Hawkey PM. Exceptional dessication tolerance of Acinetobacter radioresistans. J Hosp Infect 1998;38:235-40.
28. Jawad A, Seifert H, Snelling AM, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Micro 1998;36:1938-41.
29. Anstey NM, Currie BJ, Hassell M, et al. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002;40:685-6.
30. Leung WS, Chu CM, Tsang KY, et al. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006;129:102-9.
31. Lortholary O, Fagon JY, Bui Hoi A, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995;20:790-6.
32. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-54.
33. García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, et al. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999;27:1794-9.
34. Chen HP, Park YS, Kim CO, et al. Mortality risk factors of Acinetobacter baumanni bacteremia. J Microbiol Immuno Infect 2005;38:127-36.
35. Igra-Siegman Y, Bar-Yosef S, Gorea A, Avram J. Nosocomial Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis 1993;17:843-9.
36. Kortepeter MG, Lemmon JW, Moran KA. A soldier with traumatic brain injury and meningitis. Clin Infect Dis 2005;41:1675-6.
37. Tong MJ. Septic complications of war wounds. JAMA 1972;222:1044-7.
38. Urban C, Go E, Mariano N, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006;50:2946-50.
39. Wood GC, Hanes SD, Croce MA, et al. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of ventilator-associated pneumonia. Clin Infect Dis 2002;34:1425-30.
40. Motaouakkil S, Charra B, Hachimi A, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect 2006;53:274-8.
41. Reid GE, Grim SA, Aldeza CA, et al. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy 2007;27:1198-201.
42. Talbot GH, Bradley J, Edwards JE. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-68.
43. Hansen S, Stamm-Balderjahn S, Zuschneid I, et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 2007;65:348-53.